论文部分内容阅读
目的:分析讨论雾化吸入布地奈德对小儿肺炎的效果和影响。方法:选取本院2015年11月-2016年8月接受小儿肺炎医治病人94例,利用抽签将其平分为两组,每组47例,1组为对照组,进行常规医治;2组为观察组,在上述医治前提下添加雾化吸入布地奈德进行医治。对比两组病人病症消失时间、出院时间和总有效率。结果:观察组病症消失时间和出院时间明显少于对照组,P<0.05;观察组和对照组总有效率分别为97.87%和89.36%,观察组明显高于对照组,P<0.05。结论:雾化吸入布地奈德大大缩短了病人病症消失和出院时间,提高了康复率,可进行进一步研究。
Objective: To analyze and discuss the effect and influence of inhaled budesonide on pneumonia in children. Methods: 94 cases of pediatric pneumonia treated in our hospital from November 2015 to August 2016 were selected and equally divided into two groups by random selection. There were 47 cases in each group, one group as the control group and routine treatment. The other two groups were observed Group, in the above treatment under the premise of adding nebulized budesonide for treatment. The two groups of patients compared the disappearance of symptoms, discharge time and total effective rate. Results: The disappearance time and discharge time of the observation group were significantly less than those of the control group (P <0.05). The total effective rates of the observation group and the control group were 97.87% and 89.36%, respectively. The observation group was significantly higher than that of the control group (P <0.05). CONCLUSIONS: Inhaled budesonide significantly reduced patient morbidity and discharge and improved recovery rate, which may be further investigated.